NRGN and Alzheimer disease: In a prospective study involving 915 patients, CSF neurogranin levels were significantly and specifically elevated in Alzheimer’s disease compared with eight other neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and frontotemporal dementia [284].